An Irish product design and innovation consultancy has been chosen to work on two multi-million euro EU projects. Dolmen has been chosen to work on an €8 million project to help the future of personalised biomaterials, as well as on a €3.5 million green project on solar cells which reduces CO2 in the atmosphere.
The personalised biomaterials project will predict the patient-specific response to a given biomaterial before its implantation, allowing for the selection of the most suitable material, minimising health risks and side effects, and improving health outcomes. The ‘Personalised And/or Generalised Integrated Biomaterial Risk Assessment’ (PANBioRA) project, as it is known, is funded by Horizon 2020. The project, to be delivered over four years, involves 17 partners from 11 countries across Europe and has an overall budget of €7,992,471.
The second project Dolmen has been chosen to work on is in the area of artificial photosynthesis for new energy sources. The eSCALED project creates the European School of the Artificial Leaf, an early stage research group designed to investigate the development of an ‘artificial leaf’ with the aim of mimicking photosynthesis to develop new forms of ‘solar storage cells and fuels’ whilst simultaneously reducing CO2 in the atmosphere. The project, to be delivered over four years, involves 11 partners from 10 countries across Europe and has an overall budget of €3,599,025.
Elaborating further on Dolmen’s work, founder Sean McNulty said: “Dolmen will be delivering a series of customer-centric design thinking workshops for the researchers across Europe for the duration of the project. The aim of the workshops is to ensure that researchers always have a focus on delivering value; either through a product, a core component, technology platform or service; that can be quickly and easily integrated into existing systems and ultimately be faster to market”.
